Approval · Notice of Compliance 9262 · 2007
DIPENTUM: Notice of Compliance 9262
Issued December 20, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9262
- Date
- December 20, 2007
- Company
- Ucb Pharma Canada Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Lower gastrointestinal anti-inflammatory
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIPENTUM | Not yet assigned | — |
Medicinal ingredients
- OLSALAZINE SODIUM 250 MG per CAP